A cannabis oil production license letter of intent generated interest in a Canadian cannabis stock Thursday. Here’s some small stocks making big moves on Thursday, April 11, 2019 (as of 4 pm EST):
Revive Therapeutics Ltd. (TSXV:RVV), a Canadian cannabis stock, powered 22% higher to $0.14 on Thursday after announcing a non-binding letter of intent with Richmond Cannabis Co., for the purpose of entering into a Collaboration and Royalty agreement to establish a cannabis oil production license.
As well, shares of MTY Food Group Inc. (TSX:MTY) slipped 8% to $53.79 as the franchisor and operator of quick-service and casual dining restaurants said it has agreed to acquire Papa Murphy’s Holdings, Inc. (NASDAQ:FRSH) for US$6.45 per share in cash, or a total transaction value of approximately US$190.0 million.
The Alkaline Water Company Inc. (TSXV:WTER), meanwhile, reported that it has formed a new agreement with online grocer Peapod, which will initiate online sales of Alkaline’s premium Alkaline88 bottled water in the one-gallon container. Alkaline Water Company stock moved up 13% to $3.34 following the announcement.
Finally, Opsens Inc. (TSX:OPS) shares rose 8% to $0.82 after the provider of FFR and dPR measurement devices for interventional cardiology announced a 46% increase in its second-quarter consolidated revenue to $7.9 million.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
Revive Therapeutics Ltd. (TSXV:RVV), a Canadian cannabis stock, powered 22% higher to $0.14 on Thursday after announcing a non-binding letter of intent with Richmond Cannabis Co., for the purpose of entering into a Collaboration and Royalty agreement to establish a cannabis oil production license.
